LCM
ALBO

Laurion Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Laurion Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,000
Closed -$667K – 1028
2020
Q3 		$667K Buy
+20,000
New +$583K 0.01% 519
2018
Q2 		– Sell
-6,438
Closed -$210K – 1664
2018
Q1 		$210K Buy
+6,438
New +$217K ﹤0.01% 1215

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Laurion Capital Management's ALBO Position: Q4 2020 in Review

Laurion Capital Management sold out of Albireo Pharma Inc (ALBO) in Q4 2020, closing a stake of 20,000 shares — an estimated $667K sold.

Laurion Capital Management first reported a position in ALBO in Q1 2018 and held it in 2 quarters. The position peaked at $667K in Q3 2020. 107 funds tracked by Wall St. Rank hold ALBO as of Q4 2020.

  • Laurion Capital Management reported no remaining Albireo Pharma Inc position as of Q4 2020 after selling out during the quarter.
  • Laurion Capital Management sold 20,000 Albireo Pharma Inc shares in Q4 2020, an estimated $667K.
  • Laurion Capital Management first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 2 quarters.
  • Laurion Capital Management's Albireo Pharma Inc position peaked at $667K in Q3 2020.
  • 107 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2020.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.